Drooid Logo
Back to today’s briefing

Story perspectives

Novartis Shares Plunge 11% After Phase 3 Drug Failure

9/9/2026

3 1 Full Breakdown

1 of 1

Story summary
  • U.S. stocks fell as oil prices and bond yields pressured the S&P 500 and Nasdaq.
  • Nvidia surged to session highs after OpenAI’s GPT-6 Astra model news, then slipped nearly 2%.
  • Novartis shares dropped 11% after its Phase 3 Lp(a)-lowering drug failed to improve outcomes.
  • Amgen fell about 9%, becoming the Dow Jones’ biggest drag.
  • Boeing delivered 51 aircraft in August, with 41 737 Max jets, two more than July.